Smartest Doc
Treatment options in advanced disease
Acta Ophthalmologica, 08/09/2012
Bron A – Recent papers have highlighted that this complication may occur but may be at a lower rate that previously thought. In any case the treatment has to be customised according to the life–expectancy of the patient, the local and systemic tolerance of IOP–lowering drugs and the status of the other eye. A fair information given to the patients by the ophthalmologist is probably at least important that the suggested treatments for a given patient.